Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Vilon

KE, L-Lys-L-Glu, lysylglutamic acid

Quick Stats
Studies 40
Trials 100
Score 2
2002 pubmed

[The effect of vilon on the thymus and spleen in a radiation model of premature aging].

Kniaz'kin. I V IV; Poliakova. V O VO

Key Findings

  • Low‑dose ionizing radiation caused accelerated aging of rat thymus and spleen.
  • Administering vilon (Lys‑Glu) partially reduced the radiation‑induced aging changes.
  • The authors propose vilon as a potential candidate for geriatric research.

Practical Outcomes

  • At this stage, the study only shows a modest protective effect of vilon in a specific rat model. There is no human data, dosage guidance, or safety information, so biohackers cannot directly apply it yet. It may be worth monitoring future research for more concrete protocols.

Summary

In rats, a small amount of radiation speeds up aging in the thymus and spleen. Giving the synthetic dipeptide vilon (made of lysine and glutamic acid) partly slowed down this aging effect. The authors think vilon could be worth studying for anti‑aging purposes, but the evidence is still very early and only in animals.

Abstract

Low dose ionizing radiation induced accelerated aging of the thymus and the spleen in rat. Treatment with a synthetic dipeptide vilon (Lys-Glu) inhibited partly this process. The data suggest that vilon is a candidate for geriatric research and practice.

Study Information

Provider

pubmed

Year

2002